Search Results - Liou, Jia-Ling

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
    Gefitinib is active in patients with brain metastases from non-small cell lung cancer and response is related to skin toxicity

    Gefitinib is active in patients with brain metastases from non-small cell lung cancer and response is related to skin toxicity by Chiu, Chao-Hua, Tsai, Chun-Ming, Chen, Yuh-Min, Chiang, Shu-Chen, Liou, Jia-Ling, Perng, Reury-Perng

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Noncontact respiratory measurement of volume change using depth camera

    Noncontact respiratory measurement of volume change using depth camera by Yu, Meng-Chieh, Liou, Jia-Ling, Kuo, Shuenn-Wen, Lee, Ming-Sui, Hung, Yi-Ping

    Request full text
    Conference Proceeding
    Save to List
    Saved in:
  3. 3
    Serum tumor markers as predictors for survival in advanced non-small cell lung cancer patients treated with gefitinib

    Serum tumor markers as predictors for survival in advanced non-small cell lung cancer patients treated with gefitinib by Chiu, Chao-Hua, Shih, Yu-Ning, Tsai, Chun-Ming, Liou, Jia-Ling, Chen, Yuh-Min, Perng, Reury-Perng

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Gefitinib as front-line treatment in Chinese patients with advanced non-small-cell lung cancer

    Gefitinib as front-line treatment in Chinese patients with advanced non-small-cell lung cancer by Lin, Wei-Chun, Chiu, Chao-Hua, Liou, Jia-Ling, Chen, Yuh-Min, Perng, Reury-Perng, Tsai, Chun-Ming

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    P2-218: A phase II study of daily gefitinib plus weekly paclitaxel (GP) in Taiwanese non-small cell lung cancer (NSCLC) patients who failed gefitinib (G) or both G monotherapy and taxane (T) treatment

    P2-218: A phase II study of daily gefitinib plus weekly paclitaxel (GP) in Taiwanese non-small cell lung cancer (NSCLC) patients who failed gefitinib (G) or both G monotherapy and... by Tsai, Chun-Ming, Lai, Chun-Liang, Chiu, Chao-Hua, Liou, Jia-Ling, Chang, Kuo-Ting

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    P3-150: Phase II study of erlotinib in patients with advanced non-small cell lung cancer who failed prior gefitinib treatment

    P3-150: Phase II study of erlotinib in patients with advanced non-small cell lung cancer who failed prior gefitinib treatment by Shih, Yu-Ning, Liou, Jia-Ling, Jiang, Wan-Chian, Chang, Kao-Ting, Chiu, Chao-Hua, Tsai, Chun-Ming

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Risk of Serious Falls Between Hemodialysis and Peritoneal Dialysis Patients: A Nationwide Population-based Cohort Study

    Risk of Serious Falls Between Hemodialysis and Peritoneal Dialysis Patients: A Nationwide Population-based Cohort Study by Wang, Hsi-Hao, Wu, Jia-Ling, Lee, Yi-Che, Ho, Li-Chun, Chang, Min-Yu, Liou, Hung-Hsiang, Hung, Shih-Yuan

    Published in Scientific reports
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  8. 8
    Antibody Response and Adverse Events of AZD1222 COVID-19 Vaccination in Patients Undergoing Dialysis: A Prospective Cohort Study

    Antibody Response and Adverse Events of AZD1222 COVID-19 Vaccination in Patients Undergoing Dialysis: A Prospective Cohort Study by Wang, Hsi-Hao, Wu, Jia-Ling, Chang, Min-Yu, Wu, Hsin-Mian, Ho, Li-Chun, Chi, Po-Jui, Wu, Ching-Fang, Lee, Wan-Chia, Liou, Hung-Hsiang, Hung, Shih-Yuan, Lee, Yi-Che

    Published in Vaccines (Basel)
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  9. 9
    Activation of JNK, p38 and ERK mitogen-activated protein kinases by chromium(VI) is mediated through oxidative stress but does not affect cytotoxicity

    Activation of JNK, p38 and ERK mitogen-activated protein kinases by chromium(VI) is mediated through oxidative stress but does not affect cytotoxicity by CHUANG, S.-M, LIOU, G.-Y, YANG, J.-L

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  10. 10
    Activation of JNK, p38 and ERK mitogen-activated protein kinases by chromium(VI) is mediated through oxidative stress but does not affect cytotoxicity

    Activation of JNK, p38 and ERK mitogen-activated protein kinases by chromium(VI) is mediated through oxidative stress but does not affect cytotoxicity by Chuang, Show-Mei, Liou, Geou-Yarh, Yang, Jia-Ling

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: